Juliana O Silva1, Renata S Fernandes1, Sávia C A Lopes1, Valbert N Cardoso1, Elaine A Leite1, Geovanni D Cassali2, Maria Cristina Marzola3, Domenico Rubello3, Monica C Oliveira1, Andre Luis Branco de Barros4. 1. Faculty of Pharmacy, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627, 31270-901, Belo Horizonte, Minas Gerais, Brazil. 2. Biological Science Institute, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627, 31270-901, Belo Horizonte, Minas Gerais, Brazil. 3. Department of Radiology, Molecular Imaging, Interventional Radiology, NeuroRadiology, Medical Physics, Pathology, Biomarkers Unit, Clinical Laboratory, Microbiology Unit, Rovigo & Adria Hospital, Rovigo, Italy. 4. Faculty of Pharmacy, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627, 31270-901, Belo Horizonte, Minas Gerais, Brazil. brancodebarros@yahoo.com.br.
Abstract
PURPOSE: Therapeutic agents used in chemotherapy have low specificity leading to undesired severe side effects. Hence, the development of drug delivery systems that improve drug specificity, such as liposome moieties, is an alternative to overcome chemotherapy limitations and increase antitumor efficacy. In this study, the biodistribution profile evaluation of pH-sensitive long-circulating liposomes (SpHL) containing [99mTc]DOX in 4T1 tumor-bearing BALB/c mice is described. PROCEDURES: [99mTc]DOX was radiolabeled by direct method. Liposomes were prepared and characterized. [99mTc]DOX was encapsulated into liposomes by freezing and thawing. Circulation time for SpHL-[99mTc]DOX was determined by measuring the blood activity from healthy animals. Biodistribution studies were carried out in tumor-bearing mice at 1, 4, and 24 h after injection. RESULTS: Blood levels of the SpHL-[99mTc]DOX declined in a biphasic manner, with an α half-life of 14.1 min and β half-life of 129.0 min. High uptake was achieved in the liver and spleen, due to the macrophages captured. Moreover, tumor uptake was higher than control tissue, resulting in high tumor-to-muscle ratios, indicating higher specificity for the tumor area. CONCLUSION: [99mTc]DOX was successfully encapsulated in liposomes. Biodistribution indicated high tumor-to-muscle ratios in breast tumor-bearing BALB/c mice. In summary, these results showed the higher accumulation of SpHL-[99mTc]DOX in the tumor area, suggesting selective delivery of doxorubicin into tumor.
PURPOSE: Therapeutic agents used in chemotherapy have low specificity leading to undesired severe side effects. Hence, the development of drug delivery systems that improve drug specificity, such as liposome moieties, is an alternative to overcome chemotherapy limitations and increase antitumor efficacy. In this study, the biodistribution profile evaluation of pH-sensitive long-circulating liposomes (SpHL) containing [99mTc]DOX in 4T1 tumor-bearing BALB/c mice is described. PROCEDURES: [99mTc]DOX was radiolabeled by direct method. Liposomes were prepared and characterized. [99mTc]DOX was encapsulated into liposomes by freezing and thawing. Circulation time for SpHL-[99mTc]DOX was determined by measuring the blood activity from healthy animals. Biodistribution studies were carried out in tumor-bearing mice at 1, 4, and 24 h after injection. RESULTS: Blood levels of the SpHL-[99mTc]DOX declined in a biphasic manner, with an α half-life of 14.1 min and β half-life of 129.0 min. High uptake was achieved in the liver and spleen, due to the macrophages captured. Moreover, tumor uptake was higher than control tissue, resulting in high tumor-to-muscle ratios, indicating higher specificity for the tumor area. CONCLUSION: [99mTc]DOX was successfully encapsulated in liposomes. Biodistribution indicated high tumor-to-muscle ratios in breast tumor-bearing BALB/c mice. In summary, these results showed the higher accumulation of SpHL-[99mTc]DOX in the tumor area, suggesting selective delivery of doxorubicin into tumor.
Authors: M C de Oliveira; V Rosilio; P Lesieur; C Bourgaux; P Couvreur; M Ollivon; C Dubernet Journal: Biophys Chem Date: 2000-10-30 Impact factor: 2.352
Authors: Alvaro D C Júnior; Luciene G Mota; Elzíria A Nunan; Alberto J A Wainstein; Ana Paula D L Wainstein; Alexandre S Leal; Valbert N Cardoso; Mônica C De Oliveira Journal: Life Sci Date: 2006-10-28 Impact factor: 5.037
Authors: F I Araujo; F P P Proença; C G Ferreira; S C Ventilari; P H Rosado de Castro; R D Moreira; L M B Fonseca; S A L Souza; B Gutfilen Journal: Br J Radiol Date: 2015-05-27 Impact factor: 3.039
Authors: Anne-Kathrin Heinrich; Henrike Lucas; Lucie Schindler; Petr Chytil; Tomáš Etrych; Karsten Mäder; Thomas Mueller Journal: Mol Cancer Ther Date: 2016-03-03 Impact factor: 6.261
Authors: Charlene M Dawidczyk; Chloe Kim; Jea Ho Park; Luisa M Russell; Kwan Hyi Lee; Martin G Pomper; Peter C Searson Journal: J Control Release Date: 2014-05-27 Impact factor: 9.776
Authors: Liziane O F Monteiro; Renata S Fernandes; Luciano C Castro; Valbert N Cardoso; Mônica C Oliveira; Danyelle M Townsend; Alice Ferretti; Domenico Rubello; Elaine A Leite; André L B de Barros Journal: Biomed Pharmacother Date: 2017-03-24 Impact factor: 6.529